Skip to content
Cartherics Logo Cartherics Logo
  • Our Company
    • About Us
    • Our Vision & Mission
    • Founders
    • Board Members & Key Executives
    • Scientific Consultants
    • Partners & Collaborations
    • Our Lab
  • Technology
    • Our Technology
  • Pipeline
    • Our Pipeline
    • Scientific Publications
    • Scientific & Company Presentations
  • Careers
    • Careers at Cartherics
    • Education Opportunities
  • Latest News
  • Investors
  • Contact Us

Latest News

Home » Latest News
Latest Newscarth_admin2026-06-02T11:12:27+10:00
  • Categories: General Investor News People & Careers

    Cartherics appoints Dr Ian Nisbet as Chief Executive Officer

    Published On: November 28th, 2025

      Dr Ian Nisbet appointed as Chief Executive Officer Prof Alan Trounson AO will move into the role of Deputy [...]

    Read More
  • Categories: Conferences General People & Careers

    Cartherics to present at ANZSEV 2025

    Published On: November 17th, 2025

    Cartherics is pleased to announce that it will be presenting at the 8th Australian and New Zealand Society for Extracellular [...]

    Read More
  • Categories: General The Pipeline

    Cartherics achieves clean room certification to support clinical-grade cell therapy manufacturing

    Published On: October 27th, 2025

    Cartherics is proud to announce the successful certification of our new clean room facility, marking a significant milestone in our [...]

    Read More
  • Categories: General People & Careers

    Cartherics hosts Frocktober afternoon tea for ovarian cancer awareness

    Published On: October 15th, 2025

    Today, Cartherics proudly hosted a Frocktober Afternoon Tea in support of ovarian cancer awareness and research. Frocktober is a meaningful [...]

    Read More
  • Categories: General People & Careers

    The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet

    Published On: October 1st, 2025

    Cartherics’ COO, Dr Ian Nisbet recently joined Xtalks’ Life Science Podcast to discuss Cartherics’ vision for next generation cell therapies.   He discussed how Cartherics’ platform is building an effectively unlimited supply [...]

    Read More
  • Categories: General The Pipeline

    Cartherics Wins ‘Most Promising iPSC Therapy Pipeline in APAC’ at Asia Pacific Cell & Gene Therapy Excellence Awards

    Published On: September 11th, 2025

    Melbourne, Australia, 11 September 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies [...]

    Read More
  • Categories: General People & Careers

    Cartherics CEO Prof. Alan Trounson featured on 10News+

    Published On: September 2nd, 2025

    Cartherics is proud to share that our CEO, Professor Alan Trounson, was recently interviewed on 10 News+ by journalists Amelia [...]

    Read More
  • Categories: General The Pipeline

    Cartherics Granted Chinese Patent for Enhancing Immune Cell Function

    Published On: August 27th, 2025

    Melbourne, Australia, 27 August 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies [...]

    Read More
  • Categories: General Investor News The Pipeline

    Cartherics Unveils State-Of-The-Art Cleanroom Facility for Cell Therapy Manufacturing

    Published On: August 6th, 2025

    Melbourne, Australia, 6 August 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune stem cell [...]

    Read More
  • Categories: General People & Careers

    Congratulations Dr Mathew Tiedemann!

    Published On: July 16th, 2025

    Cartherics is pleased to announce that Mathew Tiedemann has officially completed his PhD, a major milestone in an already impressive [...]

    Read More
  • Categories: General People & Careers

    The critical importance of navigating the complexity of healthcare markets

    Published On: July 11th, 2025

    In the competitive biotech landscape, groundbreaking science alone isn't enough. As highlighted in a recent article by Dynamic Business, Cartherics' [...]

    Read More
  • Categories: Conferences General People & Careers The Pipeline

    Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025

    Published On: June 18th, 2025

    In the lead-up to BIO, Cartherics’ COO, Dr Ian Nisbet was interviewed by BioSpectrum Asia to discuss the company’s innovative [...]

    Read More
  • Categories: General The Pipeline

    Using Gene-edited Killer Cells to Target Cancer, Endometriosis and Beyond

    Published On: June 12th, 2025

    Cartherics is delighted to be featured in the June 2025 issue of Pharma Technology Focus, drawing attention to our innovative [...]

    Read More
  • Categories: Conferences General Investor News

    Cartherics to present at the 2025 BIO International Convention

    Published On: May 28th, 2025

    Cartherics’ Chief Operating Officer, Dr. Ian Nisbet, will be presenting at BIO on Monday 16th June, 2025 at 1.30pm (US [...]

    Read More
  • Categories: General People & Careers

    Bridging Borders: The Strategic Value of U.S.-Based Directors for Australian Biotech Companies

    Published On: May 19th, 2025

    Cartherics’ appointment of Laurence Nore underscores a growing trend with global implications.  As global demand for biotechnology products and services [...]

    Read More
Previous123Next
  • Our Company
  • Technology
  • Pipeline
  • Latest News
  • Investors

12 Ferntree Place
Notting Hill VIC 3168
AUSTRALIA

info@cartherics.com

+61 1300 973 415

About us

Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer and endometriosis.

Sign up to our newsletter

Stay informed about our latest news and developments

* indicates required


© Copyright 2022 – 2026| Cartherics Pty Ltd

Page load link

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Cartherics
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Go to Top